GENGOS ANDREW (Chief Financial Officer) reported 2 transactions at TERNS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/5/2026ACC: 0001563623-26-000004
Officer· Chief Financial Officer
Since Feb 2025
-996.75K
Net shares
Net seller
$5.79M
Total sold
0
Open market trades
0B · 0S
4
Total transactions
996.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−40.50K
Price / share
$53.00
Trade value
$2.15M
% of position
New position
5/5/2026
40.50K→0.00
Common Stock
Direct
Shares
−68.75K
Price / share
$53.00
Trade value
$3.64M
% of position
New position
5/5/2026
68.75K→0.00
Total
Net shares
−109.25K
Net value
-$5.79M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2026 | U · U | −40.50K | $53.00 | $2.15M | New position | 40.50K | 0.00 |
| Common Stock Direct | 5/5/2026 | D · Disposition | −68.75K | $53.00 | $3.64M | New position | 68.75K | 0.00 |
| Total | −109.25K | -$5.79M | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
750K shares
Shares
−750K
Strike price
3.73
Held after
0.00
Exercisable
—
5/5/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
137.50K shares
Shares
−137.50K
Strike price
37.18
Held after
0.00
Exercisable
—
5/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock750K shares | 5/5/2026 | D · Disposition | −750K | 3.73 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock137.50K shares | 5/5/2026 | D · Disposition | −137.50K | 37.18 | — | 0.00 |